Rabbit Recombinant Monoclonal GRSF1 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human samples. Cited in 3 publications.
View Alternative Names
G-rich sequence factor 1, GRSF-1, GRSF1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GRSF1 antibody [EPR16679] (AB194358)
Immunohistochemical analysis of paraffin-embedded Human liver tissue labeling GRSF1 with ab194358 at 1/100 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Counter stained with Hematoxylin.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-GRSF1 antibody [EPR16679] (AB194358)
Intracellular Flow Cytometry analysis of HeLa cells labelling GRSF1 (red) with purified ab194358 at dilution of 1/250. The secondary antibody used was Alexa Fluorr® 488 goat-anti-rabbit IgG (1/2000). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Isotype control antibody was Rabbit monoclonal IgG (black). The blue line shows cells without incubation with primary antibody and secondary antibody.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-GRSF1 antibody [EPR16679] (AB194358)
Immunofluorescent analysis of 4% paraformaldehyde-fixed 0.1% Triton X-100 permeabilized HeLa cells labeling GRSF1 with ab194358 at 1/100 dilution followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/400 dilution. The nuclear counter stain is DAPI (blue).
- WB
Supplier Data
Western blot - Anti-GRSF1 antibody [EPR16679] (AB194358)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-GRSF1 antibody [EPR16679] (ab194358) at 1/10000 dilution
Lane 1:
HeLa cell lysate at 20 µg
Lane 2:
293 cell lysate at 20 µg
Lane 3:
HepG2 cell lysate at 20 µg
Lane 4:
Jurkat cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 53 kDa
Observed band size: 53 kDa
false
- WB
CiteAb
Western blot - Anti-GRSF1 antibody [EPR16679] (AB194358)
GRSF1 western blot using anti-GRSF1 antibody [EPR16679] ab194358. Publication image and figure legend from Varshney, D., Cuesta, S. M., et al., 2021, Sci Rep, PubMed 34815422.
ab194358 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab194358 please see the product overview.
RNA G4s in ribosomal protein mRNA regulate translation. (a) Example snapshots demonstrating BG4 peaks in 5' UTRs and overlapping iCLAE peaks. BG4 track depict logFC of BG4 IP vs input and iCLAE track depict counts per million. (b) Western blot analysis of ribosomal protein levels following shRNA mediated depletion of DDX3X, DHX36 and GRSF1. Actin serves as loading control. Number below each lane represents fold change in ribosomal protein levels compared to non-targeting control (NTC) when normalised to actin. (c) Fold change in luminescence comparing in vitro translation of luciferase gene from wild-type ribosomal protein UTRs containing G4 (UTRQ) to mutant UTRs with G4 disruption (MutQ). (d) UV absorption at 254 nM following sucrose fractionation for polysome profiling of cells treated with DMSO (black) and 2 μM PDS (blue) for 45 min. Monosomal and polysomal fractions are highlighted. (e) Fold change in translation efficiency (logFC TE) of each transcript plotted against the significance (- log10 p-value) over three independent biological replicates. All ribosomal protein mRNAs are highlighted in red and those with significant changes (FDR < 0.1) are labelled with the corresponding protein names.
false
Related conjugates and formulations (1)
-
Anti-GRSF1 antibody [EPR16679] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The GRSF1 operates as an important player in mitochondrial RNA metabolism. It is known to interact within ribonucleoprotein complexes facilitating the regulation of mitochondrial gene expression. GRSF1 contributes to the maturation and processing of mitochondrial RNA impacting the proper synthesis of components essential for mitochondrial function. It ensures that mitochondrial encoded proteins are synthesized accurately aiding overall cellular energy production.
Pathways
GRSF1 engagement with organellar RNA processing integrates into mitochondrial biogenesis and maintenance pathways. This protein significantly influences the electron transport chain by ensuring the precise maturation of mitochondrial RNAs required for encoding electron transport chain components. It connects with proteins like LRPPRC as part of RNA granules coordinating gene expression regulation to support cellular respiration and energy conversion pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Journal of Cancer 15:4577-4590 PubMed39006084
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of Cancer 15:4175-4196 PubMed38947396
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 11:22735 PubMed34815422
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com